Bristol Myers Squibb Stock Technical Analysis
BMY Stock | USD 48.98 0.01 0.02% |
As of the 24th of April, Bristol Myers shows the Risk Adjusted Performance of 5.0E-4, standard deviation of 1.24, and Mean Deviation of 0.9389. Bristol Myers Squibb technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for thirteen technical drivers for Bristol Myers Squibb, which can be compared to its peers. Please confirm Bristol Myers Squibb coefficient of variation and value at risk to decide if Bristol Myers Squibb is priced correctly, providing market reflects its regular price of 48.98 per share. Given that Bristol Myers has information ratio of (0.08), we suggest you to validate Bristol Myers Squibb's prevailing market performance to make sure the company can sustain itself at a future point.
Bristol Myers Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Bristol, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BristolBristol |
Bristol Myers Analyst Consensus
Target Price | Advice | # of Analysts | |
71.57 | Buy | 27 | Odds |
Most Bristol analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bristol stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bristol Myers Squibb, talking to its executives and customers, or listening to Bristol conference calls.
Bristol Myers technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Bristol Myers Squibb Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Bristol Myers Squibb volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Bristol Myers Squibb Trend Analysis
Use this graph to draw trend lines for Bristol Myers Squibb. You can use it to identify possible trend reversals for Bristol Myers as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Bristol Myers price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Bristol Myers Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Bristol Myers Squibb applied against its price change over selected period. The best fit line has a slop of 0.02 , which may imply that Bristol Myers Squibb will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 21.11, which is the sum of squared deviations for the predicted Bristol Myers price change compared to its average price change.About Bristol Myers Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Bristol Myers Squibb on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Bristol Myers Squibb based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Bristol Myers Squibb price pattern first instead of the macroeconomic environment surrounding Bristol Myers Squibb. By analyzing Bristol Myers's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Bristol Myers's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Bristol Myers specific price patterns or momentum indicators. Please read more on our technical analysis page.
2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0317 | 0.0302 | 0.0447 | 0.0374 | Price To Sales Ratio | 2.99 | 3.32 | 2.36 | 2.98 |
Bristol Myers April 24, 2024 Technical Indicators
Most technical analysis of Bristol help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Bristol from various momentum indicators to cycle indicators. When you analyze Bristol charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 5.0E-4 | |||
Market Risk Adjusted Performance | (0.02) | |||
Mean Deviation | 0.9389 | |||
Coefficient Of Variation | (13,859) | |||
Standard Deviation | 1.24 | |||
Variance | 1.55 | |||
Information Ratio | (0.08) | |||
Jensen Alpha | (0.08) | |||
Total Risk Alpha | (0.19) | |||
Treynor Ratio | (0.03) | |||
Maximum Drawdown | 6.24 | |||
Value At Risk | (2.29) | |||
Potential Upside | 2.09 | |||
Skewness | (0.16) | |||
Kurtosis | 0.3211 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Bristol Stock analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.09) | Dividend Share 2.31 | Earnings Share 3.86 | Revenue Per Share 21.753 | Quarterly Revenue Growth 0.006 |
The market value of Bristol Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.